Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

AnPac Bio-Medical Raises $15 Million to Develop Early Cancer Detection Tests

publication date: Apr 12, 2022

AnPac Bio-Medical, a Shanghai-Philadelphia company focused on early cancer screening and detection, raised $15 million from Hunan Weitou Technology. Weitou will make five payments of $3 million each over the next 30 months. AnPac Bio offers many cancer screening and detection tests, including its own Cancer Differentiation Analysis (CDA), The company’s CDA technology combines an assessment of existing biomarkers with an analysis of biophysical properties and cellular proteins to provide early signals of serious health conditions and cancer. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital